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Introduction  
Progressive Supranuclear Palsy (PSP) is an uncommon neurodegenerative disease associated with postural instability, falling, and memory loss. Because of clinical similarities, 
it is often classified as atypical Parkinson's disease. PSP may present abruptly with a relatively rapid decline, leading to death in a few years. Different therapeutic approaches 
have been suggested for PSP, but their efficacy is unclear. To our knowledge, there has been no systematic review of PSP treatment.  
Objective  
To determine the effectiveness PSP treatments.    
  
  Methods 
• Literature sources: PubMed, SCOPUS and 
"gray" literature.  
• Initial inclusion criteria:  
1. English. 
2. Published between January 1, 1994 to January 
2015. 
3.  Published data on a treatment intervention for 
PSP patients. 
• Exclusion criteria:  
1. No comparison group. 
2. No clear, defined interventions. 
3. Outcome(s) that were not objective (we allowed 
opinion/observations recorded by the patient or 
a family member). 
4. Outcome assessors not blinded to the 
intervention.  
5. The control population needed to have an 
intervention similar to the experimental 
intervention (an attention sham). 
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Results 
The initial search obtained 617 publications. Of these, 28 met 
our inclusion criteria. These were grouped by therapy:           
2 dealt with an ophthalmic interventions 
 
 
 
3 with a PT/rehabilitation intervention 
 
 
 
4 with some intracranial procedures 
 
 
 
17 dealt with medications 
 
 
 
 
2 dealt with 2 or more types of intervention.  
 
 
 
 
 
 
 
 
While a number of articles had suggestive findings, 
we found only 9 acceptable articles. They either 
showed the subject therapy was not efficacious, or 
the effects were not clearly beneficial to the patient.  
A meta-analysis was not possible. 
 
Authors’ conclusions  
No therapy has been established as efficacious for 
PSP. Studies of one medication, Co-Q 10, have been 
encouraging in phase 2 study, and a phase 3 study is 
currently active. An approach using physical therapy 
(balance training) and eye movement rehabilitation 
found some benefit in gait and general mobility, but 
there was no adequate control and the overall benefit 
to patients (falls, quality of life, hospitalization,  etc.) 
was not evaluated. 
  
